Evidence map›Paper›PMID 22080898›Full record

ReviewJournal of analytical toxicology2011

The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.

Amy B Cadwallader, Carol S Lim, Douglas E Rollins, Francesco Botrè

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of analytical toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Amy B CadwalladerLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, Rome, Italy. Amy.Cadwallader@gmail.com
Carol S Lim
Douglas E Rollins
Francesco Botrè
Federazione Medico Sportiva Italiana · ITUniversity of Utah · US

Funding

DISPOSITION OF DRUGS OF ABUSE INTO HUMAN HAIRR01DA007820 · NIDA · UNIVERSITY OF UTAH · PI ROLLINS, DOUGLAS E · 1992 to 2004
$1.5M
Controlled Targeting of Proteins to Cell CompartmentsR21DK070060 · NIDDK · UNIVERSITY OF UTAH · PI LIM, CAROL S. · 2005 to 2006
$407k
Mechanism of Action of Anabolic-Androgenic SteroidsF31DA022809 · NIDA · UNIVERSITY OF UTAH · PI CADWALLADER, AMY · 2007 to 2007
$28k
NIDA NIH HHS DA07820NIDA NIH HHS F31 DA022809NIDA NIH HHS F31DA022809NIDA NIH HHS R01 DA007820NIDDK NIH HHS DK070060NIDDK NIH HHS R21 DK070060
6 · The paper itself

Abstract

Steroid abuse is a growing problem among amateur and professional athletes. Because of an inundation of newly and illegally synthesized steroids with minor structural modifications and other designer steroid receptor modulators, there is a need to develop new methods of detection which do not require prior knowledge of the abused steroid structure. The number of designer steroids currently being abused is unknown because detection methods in general are only identifying substances with a known structure. The detection of doping is moving away from merely checking for exposure to prohibited substance toward detecting an effect of prohibited substances, as biological assays can do. Cell-based biological assays are the next generation of assays which should be utilized by antidoping laboratories; they can detect androgenic anabolic steroid and other human androgen receptor (hAR) ligand presence without knowledge of their structure and assess the relative biological activity of these compounds. This review summarizes the hAR and its action and discusses its relevance to sports doping and its use in biological assays.

Indexed as

Doping in SportsAnabolic AgentsBiological AssayHumansLigandsPerformance-Enhancing SubstancesProtein BindingReceptors, AndrogenSubstance Abuse DetectionAnabolic AgentsLigandsPerformance-Enhancing SubstancesReceptors, Androgen

Identifiers

PMID22080898
PMCPMC4729460
OpenAlexW2328140187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.